Cytologic screening for cervix cancer: Each year or each 3 years?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 65, Issue 1, 1996, Pages 57-59

  Dubois, Gérard ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Cervix cancer screening interval

Indexed keywords

CANCER SCREENING; CONFERENCE PAPER; FRANCE; HEALTH PROGRAM; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0030004857     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-2243(95)02305-C     Document Type: Conference Paper

References (14)

1. Dubois G, Got C, Gremy F, Hirsch A, Tubiana M. Political action in public health an prevention. Report to the Minister of Social Affairs (in French) (1989). Santé Publique 1992; 4: 3-30.
2. Schaffer P. Les difficultés du dépistage des cancers. A propos du dépistage du cancer du col de l'utérus. In: INSERM, le Colloque CNAMTS-INSERM 1988.
3. Dubois G. Le dépistage des cancers. Situation et perspective en France. Gynécologie 1991; 42: 360-364.
4. Dubois G. Prendre le cancer de vitesse. Le Monde 14 janvier 1989.
5. Clarke EA. Does screening by 'Pap' smear help prevent cervical cancer. Lancet 1979; II: 1-4.
6. Shapiro S, Venet W, Strax P et al. Ten to fourteen years effect of screening on breast cancer mortality. J Nat Cancer Inst 1982; 69: 349-355.
7. Tabar L, Faberberg CJG, Gad A et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet 1985; I: 829-832.
8. Hakama M, Milker AB, Day NE. Screening for cancer of the uterine cervix. IARC Scientific Publications, No 76, LYON, 1986; 311
9. Van Gortmarssen GJ, Habeema JDF. Duration of pre clinical cervical cancer and reduction of incidence of invasive cancer following negative Pap smears. Int J Epidemiol 1995; 24: 300-307.
10. Fédération des centres de regroupement informatique et statistique en anatomie et cytologie pathologiques (FCRISAP). Les frottis cervico-vaginaux de dépistage. Analyse de 815 842 examens réalisés en 1992. 1994; 43.
11. Foltz AM, Kelsey JL. Le test de 'Pap' en question. Forum Mondial de la Santé 1980; I: 121-135.
12. Raffle AE, Alden B, Mackensie EFD. Detection rates for abnormal cervical smears: what are we screening for? Lancet 1995; 345: 1469-1473.
13. Skegg DCG. Cervical screening blues. Lancet 1995; 345: 1451-1452.
14. Letters to the Editor. Cervical screening: what is the point? Lancet 1995; 346: 244-247.